3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
8
Stomach Neoplasms
5
Colorectal Neoplasms
4
Pancreatic Neoplasms
3
Pain, Postoperative
3
Myoma
3
Warts
2
Rectal Neoplasms
2
Meningioma
2
Lung Neoplasms
2
Urolithiasis
1
Surgery
1
Skin Diseases
1
Sigmoid Neoplasms
1
Sarcoma
1
Recurrence
1
Radiodermatitis
1
Prostatic Neoplasms
1
Pneumoperitoneum
1
Pharyngitis
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Neuroma
1
Neuralgia
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Maxillofacial Tumors
1
Interventions
Radiotherapy
10
fludarabine phosphate
9
Peripheral Blood Stem Cell Transplantation
8
Cyclosporine
7
Cyclophosphamide
7
Busulfan
7
Whole-Body Irradiation
6
Melphalan
6
Radiofrequency Ablation
5
Mycophenolic Acid
5
Filgrastim
5
Antilymphocyte Serum
5
Surveys and Questionnaires
4
Surgical Procedures, Operative
4
Methotrexate
4
Etoposide
4
Drug Therapy
4
Cisplatin
4
fludarabine
3
Radiosurgery
3
Injections
3
Hepatectomy
3
Cord Blood Stem Cell Transplantation
3
thymoglobulin
2
lenvatinib
2
Vinblastine
2
Videotape Recording
2
Thiotepa
2
Standard of Care
2
Sorafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Recurrence
×
Sodium Chloride
×
Clear all
NCT05250791
2023-06-09
FLICOR
Imperial College London
Phase NA
Unknown
50 enrolled